His primary areas of study are Internal medicine, Positron emission tomography, Neuroscience, Pathology and Cannabinoid receptor. His study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology, Gastroenterology, Psychiatry, Ketogenic diet and Statistical parametric mapping. Within the field of Nuclear medicine and Radiology Koen Van Laere studies Positron emission tomography.
His research in Pathology intersects with topics in Amino acid and Oncology. His Cannabinoid receptor research includes themes of Insular cortex and Cannabinoid. His study in Alzheimer's disease is interdisciplinary in nature, drawing from both Biomarker, Dementia, Degenerative disease and Amyloid.
His primary scientific interests are in Internal medicine, Neuroscience, Pathology, Positron emission tomography and Nuclear medicine. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Endocrinology and Oncology. His study in Amyloid, Disease and Alzheimer's disease are all subfields of Pathology.
Koen Van Laere combines subjects such as Epilepsy, Magnetic resonance imaging, Neuroimaging and Radioligand with his study of Positron emission tomography. His research on Nuclear medicine often connects related areas such as Human brain. His Dosimetry research is multidisciplinary, incorporating perspectives in Effective dose and Biodistribution.
Koen Van Laere focuses on Nuclear medicine, Positron emission tomography, Internal medicine, Neuroscience and Neuroimaging. His work in Nuclear medicine covers topics such as Human brain which are related to areas like Effective dose. His Positron emission tomography study is related to the wider topic of Radiology.
His research integrates issues of Endocrinology and Oncology in his study of Internal medicine. His Endocrinology research incorporates themes from Metabotropic glutamate receptor 5, Alcohol Abstinence, Voxel and Amyloid. His Neuroimaging research integrates issues from Dementia, Frontotemporal dementia, Cardiology, Late life depression and Distribution.
His scientific interests lie mostly in Internal medicine, Nuclear medicine, Endocrinology, Metabotropic glutamate receptor 5 and Human brain. His Internal medicine study incorporates themes from Precentral gyrus, Magnetic resonance imaging and Voxel. Koen Van Laere interconnects Alzheimer's disease and Cerebellar cortex in the investigation of issues within Nuclear medicine.
Koen Van Laere has researched Endocrinology in several fields, including Neuropsychological assessment, Alcohol Abstinence and Effects of sleep deprivation on cognitive performance. His study explores the link between Human brain and topics such as White matter that cross with problems in Volume of distribution, Radioligand and Reference Region. His Positron emission tomography research is multidisciplinary, incorporating elements of Neurology and Endocannabinoid system.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment : a phase 2 trial.
Rik Vandenberghe;Rik Vandenberghe;Koen Van Laere;Adrian Ivanoiu;Eric Salmon.
Annals of Neurology (2010)
EANM procedure guidelines for PET brain imaging using [(18)F]FDG : version 2
Andrea Varrone;Susanne Asenbaum;Thierry Vander Borght;Jan Booij.
European Journal of Nuclear Medicine and Molecular Imaging (2009)
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.
Rik Ossenkoppele;Willemijn J Jansen;Gil D Rabinovici;Dirk L Knol.
Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1.
Arvid Suls;Peter Dedeken;Karolien Goffin;Hilde Van Esch.
[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor
H. Donald Burns;Koen Van Laere;Sandra Sanabria-Bohórquez;Terence G. Hamill.
Proceedings of the National Academy of Sciences of the United States of America (2007)
Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease
Natalie Nelissen;Koen Van Laere;Lennart Thurfjell;Rikard Owenius.
The Journal of Nuclear Medicine (2009)
EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2
Jacques Darcourt;Jan Booij;Klaus Tatsch;Andrea Varrone.
European Journal of Nuclear Medicine and Molecular Imaging (2010)
Visualizing Out-of-Body Experience in the Brain
Dirk De Ridder;Koen Van Laere;Patrick Dupont;Tomas Menovsky.
The New England Journal of Medicine (2007)
Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value
Koen Van Laere;Sarah Ceyssens;Frank Van Calenbergh;Tjibbe de Groot.
European Journal of Nuclear Medicine and Molecular Imaging (2005)
The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake.
Carol Addy;Hamish Wright;Koen Van Laere;Ira Gantz.
Cell Metabolism (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: